# Combination of MK3475 and Metronomic Cyclophosphamide in Patients With Advanced Sarcomas : Multicentre Phase II Trial

> **NCT02406781** · PHASE2 · COMPLETED · sponsor: **Institut Bergonié** · enrollment: 129 (actual)

## Conditions studied

- Sarcoma

## Interventions

- **DRUG:** Combination of MK3475 with Metronomic CP
- **DRUG:** Combination of MK3475 with Metronomic CP and G100

## Key facts

- **NCT ID:** NCT02406781
- **Lead sponsor:** Institut Bergonié
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06
- **Primary completion:** 2020-11-24
- **Final completion:** 2023-01-15
- **Target enrollment:** 129 (ACTUAL)
- **Last updated:** 2025-12-10

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02406781

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02406781, "Combination of MK3475 and Metronomic Cyclophosphamide in Patients With Advanced Sarcomas : Multicentre Phase II Trial". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT02406781. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*